![Daniel Farnum](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel Farnum
Corporate Officer/Principal bij Humboldt Medical Group, Inc.
Profiel
Daniel Farnum is currently a Co-Owner at Humboldt Medical Group, Inc. He was previously a Director at Iris BioTechnologies, Inc. Farnum received his undergraduate and doctorate degrees from The University of California, San Francisco.
Actieve functies van Daniel Farnum
Bedrijven | Functie | Begin |
---|---|---|
Humboldt Medical Group, Inc. | Corporate Officer/Principal | 02-05-2011 |
Eerdere bekende functies van Daniel Farnum
Bedrijven | Functie | Einde |
---|---|---|
IRIS BIOTECHNOLOGIES, INC. | Directeur/Bestuurslid | - |
Opleiding van Daniel Farnum
The University of California, San Francisco | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Iris BioTechnologies, Inc.
![]() Iris BioTechnologies, Inc. Medical SpecialtiesHealth Technology Iris Biotechnologies, Inc. is life sciences company focused on health care. It offers the best approach to the treatment of cancer and other diseases through actionable integration of molecular profiling in the clinical decision-making process. The Iris Nano-Biochip product pipeline include CancerChip, PrenatalChip, Integrated Blood Test, IVF applications, NeuroChip, MetabolicChip, CardioChip, and Chips for veterinary, agricultural, environmental, and other applications. The company was founded by Simon Chin on February 16, 1999 and is headquartered in Santa Clara, CA. | Health Technology |
Humboldt Medical Group, Inc. |